直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Federal Circuit IP Blog

Design Patent Claims Limited to Recited Article of Manufacture

October 28, 2021

Authored and Edited by Kelly S. Horn; Sydney R. Kestle; Elizabeth D. Ferrill

In In re: SurgiSil, L.L.P., No. 2020-1940 (Fed. Cir. Oct. 4, 2021), the Federal Circuit reversed the Board’s decision affirming an examiner’s rejection of Surgisil’s design patent application.

Surgisil’s application claims “an ornamental design for a lip implant as shown and described” in the below figure:

The examiner rejected the sole claim as anticipated by a catalog disclosing an “art tool called a stump.” The stump is made of “tightly spiral-wound, soft gray paper,” is used “for smoothing and blending large areas of pastel or charcoal,” and is shown below:

The Board affirmed the rejection, finding the differences in shape between the claimed design and the stump to be minor. It rejected Surgisil’s argument that the catalog could not anticipate the claim because it disclosed a “very different” article of manufacture than a lip implant and, in the Board’s view, “it is appropriate to ignore the identification of the article of manufacture in the claim language.” 

The Federal Circuit reversed. It held that “[a] design claim is limited to the article of manufacture identified in the claim.” Because the claim recited a “lip implant,” and the figures depicted in the application illustrate a lip implant, the Court held “the claim is limited to lip implants and does not cover other articles of manufacture.” The Board’s rejection based on prior art showing an art tool was improper despite the similar appearance between the two.

Tags

Patent Trial and Appeal Board (PTAB), prior art, validity, patentability, anticipation

Related Practices

Design Rights

Federal Circuit and Supreme Court Appeals

Patent Office Invalidation Proceedings

Related Industries

Life Sciences

Medical Device and Diagnostics

Related Offices

Washington, DC

Contacts

Kelly S. Horn
Of Counsel
Washington, DC
+1 202 408 4313
Email
Sydney R. Kestle
Partner
Washington, DC
+1 202 408 4241
Email
Elizabeth D. Ferrill
Partner
Washington, DC
+1 202 408 4445
Email

Copyright © 2021 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Virtual Seminar

Patent "Basics" Seminar

May 19, 2026

Virtual

Conference

19th Annual Forum on Pharma & Biotech Patent Litigation in Europe

May 19-20, 2026

Amsterdam

Conference

2026 Advanced Chemical & Biotech Patent Institute

May 11-12, 2026

San Francisco

Panel Discussion

Global Patent Strategies & Litigation: An Exclusive Off-the-Record Conversation with Experienced In-House Leaders

May 5, 2026

London

Articles

D. Mass. Patent Litigation Update, March 2026

D. Mass. Patent Litigation Update: March 2026

May 4, 2026

Conference

Life Sciences Patent Network North America Spring

April 29-30, 2026

Boston

At the PTAB Blog

Revvo‑lution in Discretionary Denial: Claim Construction Consistency Takes Center Stage

April 28, 2026

Articles

TOPCon v. Back-Contact Solar Cells: The Technology Race Fueled by Patent Strategy, Enforcement and Licensing

April 27, 2026

Articles

Unpacking Squires’ Recent Discretionary Denial Guidance Focusing on American Manufacturing

April 24, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP